Viatris announced that Corinne Le Goff has joined the company as Chief Commercial Officer and will become a member of the company’s Executive Leadership Team, effective April 15. Prior to joining Viatris, Le Goff was President and CEO of Imunon, a clinical-stage biotechnology company, where she led an organizational turnaround and rebranding effort.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on VTRS:
- Early notable gainers among liquid option names on April 3rd
- Ocuphire Pharma announces U.S. commercial launch of RYZUMVI
- Viatris announces U.S. commercial launch of Ryzumvi
- Viatris price target raised to $13 from $11 at Piper Sandler
- Australian Stocks: CSL Shares Retain “Strong Buy” Rating from Analysts